HAS2 and breast carcinoma: In this work, we presented a new finding on hyaluronan synthase 2 (HAS2) and the related membrane cytoskeletal cross linker protein, Ezrin, on antiestrogen resistance of receptor-positive (ER+) breast cancer cells.